Andrew Bond has over twenty years of experience in biotechnology, genomics, and computational biology research and product strategy. Prior to joining Brown, he served in executive roles at Universal Sequencing Technology, 1CellBio, Gen9, and PrimeraDx.Andrew Bond brings to BTI extensive experience in building life science startups and will support Brown life science researchers interested in commercial ventures or industry partnerships. Andrew has a PhD in Molecular Genetics from University of Massachusetts Medical School.
Brown Technology Innovations
Date
December 6, 2021
Welcome Andrew Bond to Brown Technology Innovations
Brown Technology Innovations is thrilled to have Andrew Bond join our team as Senior Director of Business Development. He will support life science researchers and inventors as they engage with our office.